
Sign up to save your podcasts
Or


We hear from a member of the pubic who experienced harm from a drug, and now advises the FDA. A former regulator who explains why reporting harms is so important. And finally, an investigative journalist who explains what "ghost management" is.
By The BMJ4.5
3232 ratings
We hear from a member of the pubic who experienced harm from a drug, and now advises the FDA. A former regulator who explains why reporting harms is so important. And finally, an investigative journalist who explains what "ghost management" is.

893 Listeners

390 Listeners

499 Listeners

47 Listeners

90 Listeners

5 Listeners

7 Listeners

5 Listeners

3 Listeners

1 Listeners

3 Listeners

9 Listeners

40 Listeners

14 Listeners

1 Listeners

51 Listeners

0 Listeners

6 Listeners

16 Listeners

99 Listeners

130 Listeners

78 Listeners

3 Listeners

23 Listeners

625 Listeners

3,812 Listeners

145 Listeners

23 Listeners

101 Listeners

2,094 Listeners

0 Listeners

110 Listeners

9 Listeners